[Elsevier] [Other]Efficacy and safety of branebrutinib (BMS-986195), an irreversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2a, randomised, double-blind, placebo-controlled study |
|
This post will be closed automatically in 2026-08-08 15:57
Reward10points
|
10
Novel Fe doped NiO-based electrode material for photoactivated catalyst and supercapacitor application
10
Evaluating the utility of perioperative laboratory tests in primary shoulder arthroplasty
10
Thermoelectric performance enhancement of copper iodide pellets through potassium iodide doping
10
The Lancet Gastroenterology & Hepatology
10
Efficient Data-Driven Model Predictive Control for Unmanned Surface Vehicles Under Model Uncertainties via Recursive Updates of a Sparse Variational Gaussian Process
